ArticleExpert opinion on therapeutic targets2011

Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? Evaluation of Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703.

Sabina Antonela AntoniuPubMed ↗Publisher ↗

No numbers read from the abstract.